International Prognostic Index (IPI)

The International Prognostic Index (IPI) is a tool used by doctors to predict the outcomes for patients with non-Hodgkin lymphoma, a type of blood cancer. It assesses five key factors: the patient's age, stage of the disease, their overall health, whether the cancer is present in certain areas, and specific blood test results. Based on these factors, patients are given a score that helps categorize their risk level, guiding treatment decisions and providing insight into potential prognosis. Essentially, the IPI helps tailor care to improve patient outcomes.